Ana‐Maria Dancau

443 total citations
8 papers, 326 citations indexed

About

Ana‐Maria Dancau is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ana‐Maria Dancau has authored 8 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ana‐Maria Dancau's work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Molecular Biology Techniques and Applications (2 papers). Ana‐Maria Dancau is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Molecular Biology Techniques and Applications (2 papers). Ana‐Maria Dancau collaborates with scholars based in Germany, Switzerland and Saudi Arabia. Ana‐Maria Dancau's co-authors include Ronald Simon, Guido Sauter, Martina Mirlacher, Jakob R. Izbicki, Jussuf T. Kaifi, Andreas H. Marx, Emre F. Yekebas, Tim H. Brümmendorf, Carsten Bokemeyer and Lars Tharun and has published in prestigious journals such as Nature Genetics, Human Pathology and Molecular Cancer Therapeutics.

In The Last Decade

Ana‐Maria Dancau

8 papers receiving 313 citations

Peers

Countries citing papers authored by Ana‐Maria Dancau

Since Specialization

Citations

This map shows the geographic impact of Ana‐Maria Dancau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana‐Maria Dancau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana‐Maria Dancau more than expected).

Fields of papers citing papers by Ana‐Maria Dancau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana‐Maria Dancau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana‐Maria Dancau. The network helps show where Ana‐Maria Dancau may publish in the future.

Co-authorship network of co-authors of Ana‐Maria Dancau

This figure shows the co-authorship network connecting the top 25 collaborators of Ana‐Maria Dancau. A scholar is included among the top collaborators of Ana‐Maria Dancau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana‐Maria Dancau. Ana‐Maria Dancau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Tissue Microarrays 2015 ·Methods in molecular biology ·Ana‐Maria Dancau, Ronald Simon, Martina Mirlacher, Guido Sauter	12
2	Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma. 2013 ·PubMed ·Alexandra König, Matthias Reeh, Ana‐Maria Dancau, (unknown), Stephanie J. Gros, Faik G. Uzunoǧlu, Maximilian Bockhorn, Ronald Simon, Guido Sauter, Andreas H. Marx, Jakob R. Izbicki	13
3	Homogeneous EGFR amplification defines a subset of aggressive Barrett’s adenocarcinomas with poor prognosis 2010 ·Histopathology ·Andreas H. Marx, (unknown), (unknown), Ana‐Maria Dancau, Sabrina Thieltges, Ronald Simon, Matthias Choschzick, Emre F. Yekebas, Jussuf T. Kaifi, Martina Mirlacher, Djordje Atanackovic, Tim H. Brümmendorf, Walter Fiedler, Carsten Bokemeyer, Jakob R. Izbicki, Guido Sauter	28
4	Effective Therapeutic Targeting of the Overexpressed HER-2 Receptor in a Highly Metastatic Orthotopic Model of Esophageal Carcinoma 2010 ·Molecular Cancer Therapeutics ·Stephanie J. Gros, (unknown), Thorsten Dohrmann, Uta Reichelt, Ana‐Maria Dancau, Kersten Peldschus, Gerhard Adam, Robert M. Hoffman, Jakob R. Izbicki, Jussuf T. Kaifi	34
5	PPFIA1 and CCND1 are frequently coamplified in breast cancer 2009 ·Genes Chromosomes and Cancer ·Ana‐Maria Dancau, (unknown), (unknown), Frederik Holst, Antje Krohn, Matthias Choschzick, Luigi Terracciano, S Politis, (unknown), Annette Lebeau, Kay Friedrichs, (unknown), Outi Monni, Ronald Simon	21
6	HER-2 amplification is highly homogenous in gastric cancer 2009 ·Human Pathology ·Andreas H. Marx, Lars Tharun, (unknown), Ana‐Maria Dancau, Ronald Simon, Emre F. Yekebas, Jussuf T. Kaifi, Martina Mirlacher, Tim H. Brümmendorf, Carsten Bokemeyer, Jakob R. Izbicki, Guido Sauter	177
7	Tissue Microarrays 2009 ·Methods in molecular biology ·Ana‐Maria Dancau, Ronald Simon, Martina Mirlacher, Guido Sauter	25
8	Reply to “ESR1 gene amplification in breast cancer: a common phenomenon?” 2008 ·Nature Genetics ·Frederik Holst, Phillip Stahl, Olaf Hellwinkel, Ana‐Maria Dancau, Antje Krohn, (unknown), (unknown), Annette Lebeau, Luigi Terracciano, Khawla S. Al‐Kuraya, F. Jänicke, Guido Sauter, Ronald Simon	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact